Vivasc Therapeutics

Pittsburgh, United States

Vivasc Therapeutics is a drug development company that specializes in proprietary cardiac targeting peptide platform technology.

$284K raised

Oct 2022

Grant

Biotechnology Health Care Medical Pharmaceutical

Top Investors

National Heart Lung and Blood Institute

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vivasc Therapeutics

How much funding has Vivasc Therapeutics raised?

Vivasc Therapeutics has raised $284K in total funding. The most recent round was Grant. The last funding was announced in October 2022.

Who are Vivasc Therapeutics's investors?

Vivasc Therapeutics's investors include National Heart, Lung and Blood Institute.

Where is Vivasc Therapeutics headquartered?

Vivasc Therapeutics is headquartered in Pittsburgh, United States.

What does Vivasc Therapeutics do?

Vivasc Therapeutics is a drug development company that specializes in proprietary cardiac targeting peptide platform technology.

What stage is Vivasc Therapeutics at?

Vivasc Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 19, 2022.

MLA

"Vivasc Therapeutics — Funding & Investors." VCBacked, October 19, 2022, https://www.vcbacked.co/company/vivasc-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Vivasc Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vivasc-therapeutics

Wikipedia (cite web)

{{cite web |title=Vivasc Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vivasc-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 19, 2022.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K